Company intelligence / Profile preview

Yangtze River Pharmaceutical Group

Taizhou, Jiangsu Province, Chinaen.yangzijiang.com ↗
Ownership
Private
Employees
~16000
Development stage
Other
01

Overview

Yangtze River Pharmaceutical Group is one of China’s largest pharmaceutical companies with over $10 billion in annual revenue. It manufactures more than 300 varieties of pharmaceuticals across chemical drugs, TCMs and biologics. The group has an extensive commercial portfolio as well as a pipeline of innovative investigational drugs—over ten are at different clinical stages—focusing on areas such as oncology and neurology. It also partners internationally to bring biosimilars to the Chinese market through collaborations like that with Alvotech & CCHT Biopharmaceuticals

Therapeutic areas
OncologyOphthalmologyImmunologyInfectious Diseases
Modalities
Small moleculestraditional Chinese medicinesbiologics including biosimilars and monoclonal antibodies
Industry
Pharma
02

Drug pipeline

23 assets

Bai'ai capsule

4

22 more assets in the full pipeline.

03

Partnerships

Alvotech & CCHT Biopharmaceutical Co., Ltd.: Commercialization of eight biosimilar candidates in China targeting autoimmunity/inflammation/oncology/ophthalmologyMabwell Bioscience Co., Ltd.: Strategic cooperation on two innovative biological drug candidates

Beyond the preview

Go deeper on Yangtze River Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangtze River Pharmaceutical Group.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call